c
x
chart
exchange
Terminal
Flow
Screener
Markets
Trends
Premium
Alerts
EST
UTC-5 New York
Blue Chip
Log in
Sign up
Revolution Medicines (RVMD) Gains EU Approval for RASONQUE in Metastatic Pancreatic Cancer
GuruFocus | Nov 16, 2026 1:26 PM EST
Related Stocks: RVMD ,
Read original article